PLoS genetics · 2026
Polygenic risk scores and Parkinson's disease in South Africa advancing ancestry informed disease prediction.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Step Kathryn, Ndong Sima Carene Anne Alene, Grant Spencer, Kim Jonggeol Jeffrey, Waldo Emily, Bardien Soraya, Mata Ignacio F, Global Parkinson’s Genetics Program (GP2)
Аннотация
Parkinson's disease (PD) is a complex neurodegenerative disorder with environmental and genetic influences. Using genotyping array data of 661 South African PD cases and 737 controls, we conduct a polygenic risk score (PRS) analysis using PRSice-2. Summary statistics from two PD association studies have been used as base datasets. We split the target dataset into training (70%; n = 979) and validation (30%; n = 419) cohorts. We test various clumping window sizes, linkage disequilibrium thresholds, and p-value thresholds to determine the optimal combination for risk prediction. Additionally, we investigate the variance explained by different combinations of covariates. Overall, we observe modest predictive performance (AUC: 0.5847-0.6183). Age at recruitment emerges as the strongest individual predictor, while sex contributes the least. These findings provide the first evaluation of PRS performance for PD in a highly admixed South African cohort, underscoring the importance of including underrepresented populations in genetic risk prediction. By systematically assessing predictive performance across two base datasets, we highlight how ancestry composition and study design affect risk estimation in diverse populations. This work lays a foundation for refining genomic prediction in admixed populations and contributes to ongoing efforts to ensure that advances in precision medicine are globally relevant.